| sterol metabolic process | GO:0016125 | 58 | 1.000 | |
| steroid metabolic process | GO:0008202 | 119 | 1.000 | |
| cholesterol metabolic process | GO:0008203 | 56 | 1.000 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.991 | |
| regulation of plasma lipoprotein particle levels | GO:0097006 | 23 | 0.988 | |
| cholesterol esterification | GO:0034435 | 3 | 0.981 | |
| cholesterol biosynthetic process | GO:0006695 | 15 | 0.980 | |
| cellular alcohol biosynthetic process | GO:0044108 | 3 | 0.980 | |
| sterol transport | GO:0015918 | 38 | 0.971 | |
| sterol biosynthetic process | GO:0016126 | 17 | 0.968 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.964 | |
| regulation of removal of superoxide radicals | GO:2000121 | 4 | 0.959 | |
| sterol esterification | GO:0034434 | 3 | 0.957 | |
| regulation of cholesterol metabolic process | GO:0090181 | 14 | 0.935 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.924 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.922 | |
| cholesterol storage | GO:0010878 | 4 | 0.916 | |
| alcohol biosynthetic process | GO:0046165 | 43 | 0.911 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.904 | |
| lipid homeostasis | GO:0055088 | 63 | 0.877 | |
| steroid esterification | GO:0034433 | 3 | 0.875 | |
| reverse cholesterol transport | GO:0043691 | 6 | 0.872 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.848 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.838 | |
| cellular alcohol metabolic process | GO:0044107 | 3 | 0.837 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.825 | |
| cholesterol transport | GO:0030301 | 38 | 0.817 | |
| sterol homeostasis | GO:0055092 | 45 | 0.813 | |
| cellular response to peptide | GO:1901653 | 92 | 0.786 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.773 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.733 | |
| regulation of sterol transport | GO:0032371 | 17 | 0.727 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.726 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.723 | |
| plasma lipoprotein particle organization | GO:0071827 | 11 | 0.691 | |
| plasma lipoprotein particle clearance | GO:0034381 | 13 | 0.683 | |
| regulation of intrinsic apoptotic signaling pathway in response to osmotic stress | GO:1902218 | 1 | 0.657 | |
| high density lipoprotein particle assembly | GO:0034380 | 3 | 0.655 | |
| glycerophospholipid metabolic process | GO:0006650 | 71 | 0.650 | |
| regulation of cholesterol biosynthetic process | GO:0045540 | 8 | 0.644 | |
| response to radiation | GO:0009314 | 165 | 0.638 | |
| lipid localization | GO:0010876 | 126 | 0.625 | |
| response to oxygen radical | GO:0000305 | 16 | 0.624 | |
| lung development | GO:0030324 | 164 | 0.624 | |
| response to low density lipoprotein particle | GO:0055098 | 2 | 0.613 | |
| protein lipid complex subunit organization | GO:0071825 | 12 | 0.611 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.609 | |
| positive regulation of sterol transport | GO:0032373 | 9 | 0.594 | |
| regulation of lipase activity | GO:0060191 | 15 | 0.574 | |
| response to amino acid | GO:0043200 | 37 | 0.574 | |
| amide transport | GO:0042886 | 138 | 0.573 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.566 | |
| cellular response to oxygen radical | GO:0071450 | 14 | 0.550 | |
| negative regulation of sterol transport | GO:0032372 | 4 | 0.546 | |
| protein lipid complex remodeling | GO:0034368 | 6 | 0.537 | |
| drug catabolic process | GO:0042737 | 2 | 0.534 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.526 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.521 | |
| positive regulation of triglyceride lipase activity | GO:0061365 | 3 | 0.518 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.514 | |
| lipid transport | GO:0006869 | 98 | 0.510 | |
| cellular response to amino acid stimulus | GO:0071230 | 29 | 0.506 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.502 | |
| respiratory tube development | GO:0030323 | 167 | 0.501 | |
| amine metabolic process | GO:0009308 | 45 | 0.498 | |
| blood circulation | GO:0008015 | 195 | 0.497 | |
| very low density lipoprotein particle remodeling | GO:0034372 | 1 | 0.491 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.491 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.489 | Rat |
| extracellular matrix organization | GO:0030198 | 147 | 0.489 | |
| innate immune response | GO:0045087 | 157 | 0.483 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.483 | |
| mating behavior sex discrimination | GO:0048047 | 1 | 0.479 | |
| negative regulation of growth of symbiont involved in interaction with host | GO:0044146 | 19 | 0.474 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.471 | |
| metanephric glomerular mesangium development | GO:0072223 | 3 | 0.470 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.469 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.466 | |
| regulation of cell migration | GO:0030334 | 219 | 0.461 | |
| regulation of growth of symbiont in host | GO:0044126 | 19 | 0.457 | |
| cellular response to lipid | GO:0071396 | 145 | 0.455 | |
| ovarian follicle development | GO:0001541 | 40 | 0.449 | |
| luteinization | GO:0001553 | 8 | 0.448 | |
| negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:2000162 | 1 | 0.445 | |
| positive regulation of lipase activity | GO:0060193 | 6 | 0.445 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.441 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.437 | |
| positive regulation of cholesterol transport | GO:0032376 | 9 | 0.436 | |
| removal of superoxide radicals | GO:0019430 | 12 | 0.434 | |
| positive regulation of presynaptic membrane organization | GO:1901631 | 1 | 0.432 | |
| phospholipid transport | GO:0015914 | 21 | 0.426 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.425 | |
| jak stat cascade | GO:0007259 | 42 | 0.424 | |
| sphingolipid metabolic process | GO:0006665 | 45 | 0.421 | |
| positive regulation of lipoprotein lipase activity | GO:0051006 | 3 | 0.414 | |
| respiratory system development | GO:0060541 | 190 | 0.414 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.413 | |
| activation of mapkk activity | GO:0000186 | 15 | 0.402 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.402 | |
| digestive tract development | GO:0048565 | 190 | 0.392 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.389 | |
| plasma lipoprotein particle remodeling | GO:0034369 | 6 | 0.389 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.379 | |
| response to peptide hormone | GO:0043434 | 127 | 0.378 | Rat |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.376 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.374 | |
| membrane lipid metabolic process | GO:0006643 | 53 | 0.374 | |
| positive regulation of nitric oxide synthase activity | GO:0051000 | 2 | 0.374 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.364 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.361 | |
| cytokine production involved in immune response | GO:0002367 | 34 | 0.355 | |
| steroid biosynthetic process | GO:0006694 | 47 | 0.354 | |
| response to steroid hormone | GO:0048545 | 56 | 0.353 | Rat |
| cation homeostasis | GO:0055080 | 212 | 0.351 | |
| cellular response to superoxide | GO:0071451 | 14 | 0.350 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.344 | Mouse |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.337 | |
| tyrosine phosphorylation of stat protein | GO:0007260 | 23 | 0.335 | |
| regulation of adrenergic receptor signaling pathway | GO:0071877 | 4 | 0.332 | |
| extracellular structure organization | GO:0043062 | 148 | 0.331 | |
| negative regulation of cellular amide metabolic process | GO:0034249 | 4 | 0.322 | |
| negative regulation of cholesterol transport | GO:0032375 | 4 | 0.319 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.316 | |
| elastic fiber assembly | GO:0048251 | 4 | 0.315 | |
| cholesterol efflux | GO:0033344 | 24 | 0.313 | |
| maintenance of location | GO:0051235 | 89 | 0.310 | |
| regulation of cholesterol transport | GO:0032374 | 17 | 0.309 | |
| lipoprotein metabolic process | GO:0042157 | 43 | 0.304 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.302 | |
| response to hyperoxia | GO:0055093 | 2 | 0.298 | |
| cellular response to interleukin 18 | GO:0071351 | 3 | 0.295 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.291 | |
| response to superoxide | GO:0000303 | 16 | 0.286 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.284 | |
| response to increased oxygen levels | GO:0036296 | 2 | 0.282 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.280 | Mouse |
| negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | GO:1902239 | 1 | 0.273 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.272 | |
| oxidation reduction process | GO:0055114 | 342 | 0.271 | |
| circulatory system process | GO:0003013 | 197 | 0.270 | |
| cell chemotaxis | GO:0060326 | 81 | 0.265 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.261 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.261 | |
| cdc42 protein signal transduction | GO:0032488 | 0 | 0.261 | |
| interleukin 18 mediated signaling pathway | GO:0035655 | 2 | 0.257 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.253 | |
| regulation of neurotrophin trk receptor signaling pathway | GO:0051386 | 4 | 0.251 | |
| acylglycerol biosynthetic process | GO:0046463 | 18 | 0.250 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.250 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.249 | |
| positive regulation of triglyceride metabolic process | GO:0090208 | 9 | 0.246 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.245 | |
| regulation of response to oxidative stress | GO:1902882 | 19 | 0.245 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.244 | Mouse |
| regulation of secretion | GO:0051046 | 274 | 0.242 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.241 | |
| defense response to other organism | GO:0098542 | 197 | 0.241 | |
| response to oxidative stress | GO:0006979 | 123 | 0.241 | |
| heart contraction | GO:0060047 | 93 | 0.241 | |
| regulation of beta amyloid clearance | GO:1900221 | 1 | 0.240 | |
| regulation of tissue remodeling | GO:0034103 | 38 | 0.239 | |
| skin development | GO:0043588 | 220 | 0.238 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.237 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.236 | |
| organophosphate ester transport | GO:0015748 | 28 | 0.235 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.233 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.233 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.232 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.231 | |
| response to acid chemical | GO:0001101 | 111 | 0.231 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.230 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.226 | |
| regulation of system process | GO:0044057 | 200 | 0.225 | |
| face morphogenesis | GO:0060325 | 29 | 0.225 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.222 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.220 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.220 | Rat |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.219 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.218 | |
| response to insulin | GO:0032868 | 100 | 0.217 | |
| forebrain development | GO:0030900 | 302 | 0.215 | Mouse |
| acylglycerol homeostasis | GO:0055090 | 16 | 0.213 | |
| platelet derived growth factor receptor alpha signaling pathway | GO:0035790 | 3 | 0.213 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.212 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.209 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.207 | |
| drug metabolic process | GO:0017144 | 4 | 0.207 | |
| angiogenesis | GO:0001525 | 201 | 0.200 | |
| cartilage development | GO:0051216 | 140 | 0.199 | |
| detection of molecule of bacterial origin | GO:0032490 | 2 | 0.198 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.198 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.198 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.195 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.195 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.194 | Mouse |
| limb morphogenesis | GO:0035108 | 149 | 0.194 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.194 | |
| smooth muscle cell chemotaxis | GO:0071670 | 2 | 0.193 | |
| lung alveolus development | GO:0048286 | 45 | 0.192 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.192 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.191 | |
| regulation of phospholipase c activity | GO:1900274 | 3 | 0.191 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.190 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.188 | |
| tissue homeostasis | GO:0001894 | 115 | 0.186 | |
| intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | GO:1990127 | 1 | 0.185 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.185 | |
| hormone secretion | GO:0046879 | 128 | 0.185 | |
| regulation of fatty acid metabolic process | GO:0019217 | 28 | 0.184 | |
| bone mineralization | GO:0030282 | 54 | 0.183 | |
| regulation of phosphatidylcholine catabolic process | GO:0010899 | 2 | 0.181 | |
| response to growth factor | GO:0070848 | 198 | 0.181 | |
| regulation of phospholipid efflux | GO:1902994 | 2 | 0.179 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.177 | |
| epidermis development | GO:0008544 | 187 | 0.176 | |
| protein catabolic process | GO:0030163 | 221 | 0.173 | |
| negative regulation of peptide hormone secretion | GO:0090278 | 16 | 0.173 | |
| negative regulation of systemic arterial blood pressure | GO:0003085 | 15 | 0.173 | |
| cytokine production | GO:0001816 | 319 | 0.172 | |
| regulation of cholesterol esterification | GO:0010872 | 2 | 0.172 | |
| exogenous drug catabolic process | GO:0042738 | 1 | 0.171 | |
| regulation of jak stat cascade | GO:0046425 | 34 | 0.170 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.170 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.169 | |
| negative regulation of blood vessel endothelial cell migration | GO:0043537 | 3 | 0.168 | |
| positive regulation of apoptotic cell clearance | GO:2000427 | 3 | 0.167 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.166 | |
| superoxide metabolic process | GO:0006801 | 27 | 0.166 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.165 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.164 | |
| bone morphogenesis | GO:0060349 | 78 | 0.163 | |
| head morphogenesis | GO:0060323 | 34 | 0.163 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.162 | |
| regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | GO:1902238 | 1 | 0.162 | |
| positive regulation of metanephros development | GO:0072216 | 9 | 0.162 | |
| response to inorganic substance | GO:0010035 | 96 | 0.161 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.161 | |
| positive regulation of lipid storage | GO:0010884 | 10 | 0.161 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.160 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.160 | |
| positive regulation of cholesterol esterification | GO:0010873 | 1 | 0.159 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.159 | |
| modulation of growth of symbiont involved in interaction with host | GO:0044144 | 19 | 0.158 | |
| skeletal system development | GO:0001501 | 356 | 0.158 | |
| phospholipase c activating angiotensin activated signaling pathway | GO:0086097 | 1 | 0.158 | |
| regulation of lipoprotein lipase activity | GO:0051004 | 4 | 0.157 | |
| response to sterol | GO:0036314 | 4 | 0.157 | |
| regulation of response to reactive oxygen species | GO:1901031 | 9 | 0.155 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.155 | |
| muscle contraction | GO:0006936 | 101 | 0.154 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.153 | |
| heart process | GO:0003015 | 94 | 0.153 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.151 | |
| vasodilation by angiotensin involved in regulation of systemic arterial blood pressure | GO:0002033 | 2 | 0.150 | |
| g protein coupled receptor signaling pathway coupled to cgmp nucleotide second messenger | GO:0007199 | 1 | 0.148 | |
| negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis | GO:2000149 | 1 | 0.147 | |
| platelet derived growth factor receptor signaling pathway | GO:0048008 | 32 | 0.146 | |
| intracellular cholesterol transport | GO:0032367 | 3 | 0.145 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.145 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.145 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.144 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.143 | |
| positive regulation of phospholipase activity | GO:0010518 | 3 | 0.143 | |
| lipid modification | GO:0030258 | 65 | 0.141 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.140 | |
| hormone metabolic process | GO:0042445 | 86 | 0.139 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.137 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.137 | |
| regulation of b cell differentiation | GO:0045577 | 23 | 0.137 | |
| intrinsic apoptotic signaling pathway in response to osmotic stress | GO:0008627 | 2 | 0.136 | |
| response to monosaccharide | GO:0034284 | 67 | 0.136 | |
| modulation by symbiont of defense related host nitric oxide production | GO:0052163 | 1 | 0.136 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.135 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.135 | |
| glucose homeostasis | GO:0042593 | 128 | 0.134 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.133 | |
| defense response to bacterium | GO:0042742 | 119 | 0.133 | |
| regulation of renal output by angiotensin | GO:0002019 | 2 | 0.133 | |
| positive regulation of dendrite development | GO:1900006 | 21 | 0.133 | Mouse |
| fatty acid metabolic process | GO:0006631 | 121 | 0.132 | |
| regulation of immune complex clearance by monocytes and macrophages | GO:0090264 | 2 | 0.131 | |
| interleukin 33 mediated signaling pathway | GO:0038172 | 1 | 0.131 | |
| lipoprotein biosynthetic process | GO:0042158 | 33 | 0.131 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.129 | |
| positive regulation of triglyceride biosynthetic process | GO:0010867 | 6 | 0.128 | |
| vasodilation | GO:0042311 | 28 | 0.128 | |
| intestinal absorption | GO:0050892 | 13 | 0.128 | Human |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.128 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.127 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.126 | Mouse |
| regulation of intestinal cholesterol absorption | GO:0030300 | 4 | 0.126 | |
| calcium ion transport | GO:0006816 | 159 | 0.125 | |
| muscle tissue development | GO:0060537 | 308 | 0.124 | |
| defense response to gram positive bacterium | GO:0050830 | 50 | 0.124 | |
| sterol transmembrane transport | GO:0035382 | 2 | 0.123 | |
| growth of symbiont involved in interaction with host | GO:0044116 | 23 | 0.121 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.120 | |
| organic acid transport | GO:0015849 | 101 | 0.120 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.120 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 47 | 0.120 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.119 | |
| growth of symbiont in host | GO:0044117 | 23 | 0.119 | |
| high density lipoprotein particle remodeling | GO:0034375 | 4 | 0.119 | |
| positive regulation of cholesterol storage | GO:0010886 | 3 | 0.117 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.117 | |
| glycosylation | GO:0070085 | 62 | 0.117 | |
| positive regulation of cholesterol efflux | GO:0010875 | 9 | 0.117 | |
| regulation of cellular response to oxidative stress | GO:1900407 | 19 | 0.117 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.116 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.116 | |
| apoptotic process involved in mammary gland involution | GO:0060057 | 4 | 0.116 | |
| plasma lipoprotein particle assembly | GO:0034377 | 6 | 0.116 | |
| triglyceride rich lipoprotein particle remodeling | GO:0034370 | 2 | 0.116 | |
| protein glycosylation | GO:0006486 | 55 | 0.115 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.115 | |
| bone resorption | GO:0045453 | 38 | 0.114 | |
| response to nutrient levels | GO:0031667 | 109 | 0.114 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.113 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.113 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.111 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.110 | |
| regulation of blood vessel remodeling | GO:0060312 | 3 | 0.109 | |
| response to macrophage colony stimulating factor | GO:0036005 | 3 | 0.109 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.108 | |
| leukocyte migration | GO:0050900 | 124 | 0.108 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.108 | |
| regulation of steroid metabolic process | GO:0019218 | 39 | 0.108 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.107 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.106 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.104 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.104 | |
| growth involved in symbiotic interaction | GO:0044110 | 23 | 0.104 | |
| response to estrogen | GO:0043627 | 24 | 0.104 | Rat |
| cardiocyte differentiation | GO:0035051 | 87 | 0.103 | |
| positive regulation of monooxygenase activity | GO:0032770 | 2 | 0.102 | |
| response to vitamin a | GO:0033189 | 1 | 0.102 | |
| protein maturation | GO:0051604 | 176 | 0.101 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.101 | Mouse |
| regulation of planar cell polarity pathway involved in ventricular septum morphogenesis | GO:2000148 | 1 | 0.101 | |
| insulin receptor signaling pathway | GO:0008286 | 49 | 0.101 | |
| negative regulation of planar cell polarity pathway involved in pericardium morphogenesis | GO:2000166 | 1 | 0.100 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.100 | |
| t cell activation | GO:0042110 | 289 | 0.100 | |
| negative regulation of response to cytokine stimulus | GO:0060761 | 9 | 0.100 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.100 | |
| liver development | GO:0001889 | 66 | 0.100 | |
| antibacterial peptide secretion | GO:0002779 | 1 | 0.100 | |
| regulation of cell activation | GO:0050865 | 289 | 0.099 | |
| negative regulation of insulin secretion | GO:0046676 | 14 | 0.099 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.099 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.098 | |
| protein processing | GO:0016485 | 163 | 0.098 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.098 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.098 | |
| regulation of monooxygenase activity | GO:0032768 | 7 | 0.097 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.096 | |
| organ regeneration | GO:0031100 | 2 | 0.096 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.096 | |
| serotonin uptake | GO:0051610 | 3 | 0.095 | |
| macrophage colony stimulating factor signaling pathway | GO:0038145 | 2 | 0.095 | |
| appendage development | GO:0048736 | 166 | 0.094 | |
| odontogenesis | GO:0042476 | 78 | 0.094 | |
| palate development | GO:0060021 | 76 | 0.092 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.092 | |
| female gonad development | GO:0008585 | 71 | 0.092 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.091 | |
| positive regulation of bone remodeling | GO:0046852 | 13 | 0.091 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.091 | |
| cholesterol import | GO:0070508 | 2 | 0.091 | |
| regulation of symbiosis encompassing mutualism through parasitism | GO:0043903 | 52 | 0.091 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.091 | |
| regulation of cholesterol efflux | GO:0010874 | 13 | 0.091 | |
| white fat cell differentiation | GO:0050872 | 15 | 0.090 | |
| ossification | GO:0001503 | 216 | 0.090 | |
| negative regulation of smooth muscle cell apoptotic process | GO:0034392 | 1 | 0.090 | |
| positive regulation of cell substrate adhesion | GO:0010811 | 47 | 0.090 | |
| rhythmic process | GO:0048511 | 174 | 0.089 | |
| phospholipid efflux | GO:0033700 | 3 | 0.089 | |
| cellular amino acid catabolic process | GO:0009063 | 25 | 0.089 | |
| triglyceride biosynthetic process | GO:0019432 | 17 | 0.089 | |
| cellular response to macrophage colony stimulating factor stimulus | GO:0036006 | 3 | 0.088 | |
| positive regulation of dna biosynthetic process | GO:2000573 | 4 | 0.088 | |
| toxin transport | GO:1901998 | 38 | 0.087 | |
| negative regulation of cholesterol efflux | GO:0090370 | 4 | 0.087 | |
| metanephric glomerulus morphogenesis | GO:0072275 | 3 | 0.087 | |
| chemotaxis | GO:0006935 | 247 | 0.087 | |
| modification of morphology or physiology of other organism involved in symbiotic interaction | GO:0051817 | 16 | 0.086 | |
| negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress | GO:1902219 | 1 | 0.086 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.086 | |
| regulation of defense response | GO:0031347 | 233 | 0.086 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.086 | |
| tissue remodeling | GO:0048771 | 102 | 0.085 | |
| chromatin modification | GO:0016568 | 187 | 0.085 | |
| cellular homeostasis | GO:0019725 | 240 | 0.085 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.084 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.084 | |
| angiogenesis involved in coronary vascular morphogenesis | GO:0060978 | 2 | 0.084 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.083 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.083 | |
| female sex differentiation | GO:0046660 | 84 | 0.083 | |
| ovulation cycle | GO:0042698 | 59 | 0.083 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.082 | |
| regulation of phospholipid transport | GO:2001138 | 4 | 0.082 | |
| regulation of inclusion body assembly | GO:0090083 | 1 | 0.082 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.082 | Mouse |
| regulation of lipid transport | GO:0032368 | 36 | 0.081 | |
| regulation of phospholipase a2 activity | GO:0032429 | 3 | 0.080 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.080 | |
| cellular response to erythropoietin | GO:0036018 | 1 | 0.080 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.080 | |
| striated muscle contraction | GO:0006941 | 45 | 0.080 | |
| positive regulation of extrinsic apoptotic signaling pathway | GO:2001238 | 34 | 0.080 | |
| fat cell differentiation | GO:0045444 | 160 | 0.080 | |
| lipid storage | GO:0019915 | 36 | 0.079 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.079 | |
| tyrosine phosphorylation of stat3 protein | GO:0042503 | 12 | 0.079 | |
| regulation of membrane protein ectodomain proteolysis | GO:0051043 | 3 | 0.078 | |
| negative regulation of heart rate | GO:0010459 | 4 | 0.078 | |
| alpha amino acid catabolic process | GO:1901606 | 18 | 0.078 | |
| regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:2000150 | 1 | 0.078 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.077 | |
| negative regulation of peptide secretion | GO:0002792 | 16 | 0.077 | |
| bone development | GO:0060348 | 120 | 0.077 | |
| chromatin organization | GO:0006325 | 206 | 0.077 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.076 | |
| i kappab phosphorylation | GO:0007252 | 6 | 0.076 | |
| hair follicle development | GO:0001942 | 85 | 0.076 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.076 | |
| regulation of mesenchymal cell proliferation | GO:0010464 | 37 | 0.076 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.076 | Mouse |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.076 | |
| negative regulation of neurotrophin trk receptor signaling pathway | GO:0051387 | 2 | 0.075 | |
| negative regulation of secretion by cell | GO:1903531 | 54 | 0.075 | |
| cell adhesion | GO:0007155 | 329 | 0.075 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.075 | |
| epidermal growth factor receptor signaling pathway | GO:0007173 | 28 | 0.074 | |
| regulation of cell motility | GO:2000145 | 236 | 0.074 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.074 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.074 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.073 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.073 | |
| kit signaling pathway | GO:0038109 | 3 | 0.072 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.072 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.072 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.072 | |
| low density lipoprotein particle clearance | GO:0034383 | 8 | 0.072 | |
| regulation of blood coagulation | GO:0030193 | 28 | 0.072 | |
| negative regulation of reactive oxygen species biosynthetic process | GO:1903427 | 0 | 0.072 | |
| induction by organism of immune response of other organism involved in symbiotic interaction | GO:0052558 | 1 | 0.071 | |
| response to lipoprotein particle | GO:0055094 | 5 | 0.071 | |
| membrane protein proteolysis | GO:0033619 | 10 | 0.071 | |
| lipid catabolic process | GO:0016042 | 69 | 0.071 | |
| beta amyloid clearance | GO:0097242 | 2 | 0.071 | |
| negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis | GO:2000164 | 1 | 0.071 | |
| endocytosis | GO:0006897 | 168 | 0.070 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.070 | |
| nuclear import | GO:0051170 | 95 | 0.070 | |
| positive regulation of tissue remodeling | GO:0034105 | 19 | 0.070 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.070 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.069 | |
| regulation of cholesterol storage | GO:0010885 | 4 | 0.069 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.069 | Mouse |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.069 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.069 | |
| transmembrane transport | GO:0055085 | 412 | 0.069 | |
| humoral immune response | GO:0006959 | 57 | 0.068 | |
| face development | GO:0060324 | 38 | 0.068 | |
| glutamine family amino acid catabolic process | GO:0009065 | 5 | 0.068 | |
| cellular response to thyroid hormone stimulus | GO:0097067 | 1 | 0.068 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.068 | |
| negative regulation of b cell activation | GO:0050869 | 27 | 0.068 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.068 | |
| metanephric nephron development | GO:0072210 | 34 | 0.067 | |
| response to oxygen levels | GO:0070482 | 62 | 0.067 | Rat |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.067 | |
| positive regulation of behavior | GO:0048520 | 40 | 0.067 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.067 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.066 | |
| male sex differentiation | GO:0046661 | 109 | 0.066 | |
| heart morphogenesis | GO:0003007 | 178 | 0.066 | |
| connective tissue development | GO:0061448 | 179 | 0.066 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.065 | |
| endocrine system development | GO:0035270 | 98 | 0.065 | |
| dendritic cell cytokine production | GO:0002371 | 3 | 0.065 | |
| response to bacterial lipoprotein | GO:0032493 | 4 | 0.065 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.065 | |
| spermatid development | GO:0007286 | 108 | 0.065 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.064 | |
| positive regulation of interferon alpha production | GO:0032727 | 4 | 0.064 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.064 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.064 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.064 | |
